Drugs / Ganshuang
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT05523648 | Jan 2020 → Dec 2021 | NAFLD1, chronic hepatitis B virus infection | Sichuan Leshan Traditional Chinese Medicine Hospital | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ganshuang | “The treatment group was treated with Ganshuang granules combined with silibinin meglumine tablets and tenofovir.” NCT05523648 ↗ |